ArticleTheranostics2020

Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts.

Florence Coussy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.